Advanced search
1 file | 717.09 KB Add to list

High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity.

Fréderic Duprez (UGent) , Dieter Berwouts (UGent) , Indira Madani (UGent) , Katrien Bonte (UGent) , Tom Boterberg (UGent) , Werner De Gersem (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) and Wilfried De Neve (UGent)
(2014) RADIOTHERAPY AND ONCOLOGY. 111(3). p.388-392
Author
Organization
Keywords
Toxicity, SQUAMOUS-CELL CARCINOMA, Reirradiation, IMRT, Head-and-neck cancer, Radiotherapy, OUTCOMES, FEASIBILITY, TRIAL, SALVAGE SURGERY, RADIATION-THERAPY, LOCALLY-RECURRENT, CAROTID BLOWOUT, CHEMOTHERAPY, CETUXIMAB

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 717.09 KB

Citation

Please use this url to cite or link to this publication:

MLA
Duprez, Fréderic, Dieter Berwouts, Indira Madani, et al. “High-dose Reirradiation with Intensity-modulated Radiotherapy for Recurrent Head-and-neck Cancer: Disease Control, Survival and Toxicity.” RADIOTHERAPY AND ONCOLOGY 111.3 (2014): 388–392. Print.
APA
Duprez, F., Berwouts, D., Madani, I., Bonte, K., Boterberg, T., De Gersem, W., Deron, P., et al. (2014). High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity. RADIOTHERAPY AND ONCOLOGY, 111(3), 388–392.
Chicago author-date
Duprez, Fréderic, Dieter Berwouts, Indira Madani, Katrien Bonte, Tom Boterberg, Werner De Gersem, Philippe Deron, Wouter Huvenne, and Wilfried De Neve. 2014. “High-dose Reirradiation with Intensity-modulated Radiotherapy for Recurrent Head-and-neck Cancer: Disease Control, Survival and Toxicity.” Radiotherapy and Oncology 111 (3): 388–392.
Chicago author-date (all authors)
Duprez, Fréderic, Dieter Berwouts, Indira Madani, Katrien Bonte, Tom Boterberg, Werner De Gersem, Philippe Deron, Wouter Huvenne, and Wilfried De Neve. 2014. “High-dose Reirradiation with Intensity-modulated Radiotherapy for Recurrent Head-and-neck Cancer: Disease Control, Survival and Toxicity.” Radiotherapy and Oncology 111 (3): 388–392.
Vancouver
1.
Duprez F, Berwouts D, Madani I, Bonte K, Boterberg T, De Gersem W, et al. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity. RADIOTHERAPY AND ONCOLOGY. 2014;111(3):388–92.
IEEE
[1]
F. Duprez et al., “High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity.,” RADIOTHERAPY AND ONCOLOGY, vol. 111, no. 3, pp. 388–392, 2014.
@article{5663595,
  author       = {Duprez, Fréderic and Berwouts, Dieter and Madani, Indira and Bonte, Katrien and Boterberg, Tom and De Gersem, Werner and Deron, Philippe and Huvenne, Wouter and De Neve, Wilfried},
  issn         = {0167-8140},
  journal      = {RADIOTHERAPY AND ONCOLOGY},
  keywords     = {Toxicity,SQUAMOUS-CELL CARCINOMA,Reirradiation,IMRT,Head-and-neck cancer,Radiotherapy,OUTCOMES,FEASIBILITY,TRIAL,SALVAGE SURGERY,RADIATION-THERAPY,LOCALLY-RECURRENT,CAROTID BLOWOUT,CHEMOTHERAPY,CETUXIMAB},
  language     = {eng},
  number       = {3},
  pages        = {388--392},
  title        = {High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity.},
  url          = {http://dx.doi.org/10.1016/j.radonc.2014.04.018},
  volume       = {111},
  year         = {2014},
}

Altmetric
View in Altmetric
Web of Science
Times cited: